Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Fruit flies illuminate the role of Alzheimer's disease risk genes

Fruit flies illuminate the role of Alzheimer's disease risk genes

UCSF receives historic $100 million gift for Memory and Aging Center

UCSF receives historic $100 million gift for Memory and Aging Center

Exploring the gut-brain-immune axis in neurodegeneration

Exploring the gut-brain-immune axis in neurodegeneration

Daily 40Hz audiovisual stimulation may slow cognitive decline in late-onset Alzheimer's patients

Daily 40Hz audiovisual stimulation may slow cognitive decline in late-onset Alzheimer's patients

New discovery reshapes understanding of how brain inflammation arises in Alzheimer's disease

New discovery reshapes understanding of how brain inflammation arises in Alzheimer's disease

Revolutionizing gait analysis with wearable sensors and 3D depth cameras

Revolutionizing gait analysis with wearable sensors and 3D depth cameras

Les Turner Symposium on ALS brings researchers and clinicians to discuss new research findings

Les Turner Symposium on ALS brings researchers and clinicians to discuss new research findings

Disruption of glial circadian rhythms linked to Alzheimer's disease progression

Disruption of glial circadian rhythms linked to Alzheimer's disease progression

People with multiple sclerosis found to have dysbiotic oral microbiome

People with multiple sclerosis found to have dysbiotic oral microbiome

Fortress, filter, and gatekeeper: New insights into how the blood-brain barrier safeguards the brain

Fortress, filter, and gatekeeper: New insights into how the blood-brain barrier safeguards the brain

Earlier menopause and reduced cardiac function may negatively affect brain health

Earlier menopause and reduced cardiac function may negatively affect brain health

Study offers a nuanced understanding of how bedroom ventilation affects sleep health

Study offers a nuanced understanding of how bedroom ventilation affects sleep health

Genetic and inflammatory factors amplify the link between earlier menopause and cognitive risk

Genetic and inflammatory factors amplify the link between earlier menopause and cognitive risk

Transdermal hormone therapy offers potential reduction in anxiety and depression

Transdermal hormone therapy offers potential reduction in anxiety and depression

Heavy drinking fuels Alzheimer’s disease by igniting brain inflammation and protein damage

Heavy drinking fuels Alzheimer’s disease by igniting brain inflammation and protein damage

Social and environmental inequality linked to risk of Alzheimer’s

Social and environmental inequality linked to risk of Alzheimer’s

Study reveals how a microglial mutation increases risk for Alzheimer's disease

Study reveals how a microglial mutation increases risk for Alzheimer's disease

New 3D human brain tissue platform integrates all major brain cell types into a single culture

New 3D human brain tissue platform integrates all major brain cell types into a single culture

Restoring pleiotrophin shows promise for improving brain function in Down syndrome

Restoring pleiotrophin shows promise for improving brain function in Down syndrome

Advanced MRI technique reveals early markers of hereditary frontotemporal dementia

Advanced MRI technique reveals early markers of hereditary frontotemporal dementia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.